about
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virusChanges in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationGenome-wide meta-analyses identify three loci associated with primary biliary cirrhosisIndividualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.Study of corneal copper deposits in Wilson's disease by in vivo confocal microscopy.Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosisHypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.Innate immunity and primary biliary cirrhosis.Oxysterols in bile acid metabolism.Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions.ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients.Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis.Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.Body mass index, cardiovascular risk factors, and carotid intima-media thickness in a pediatric population in southern Italy.Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability.Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection.Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: a prospective study.Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey.Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.Regenerative nodules in patients with chronic Budd-Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT.A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis.Acute liver and renal failure during treatment with buprenorphine at therapeutic dose.Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis.Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.Repeated bile acid therapy for the long-term management of cholesterol gallstones.Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy.Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.X monosomy in female systemic lupus erythematosus.Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis.Blood fetal microchimerism in primary biliary cirrhosis.Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trialChanges in classic and alternative pathways of bile acid synthesis in chronic liver disease
P50
Q27486882-7CC32BFE-FFB6-4140-8E4F-42827DDD6DD9Q28334026-35515DD9-C047-4606-AC1B-C8C6B24AED92Q28943317-F25869C7-E7E2-4E70-B3BD-87D60EB336F9Q34395502-1EA2231C-F3DE-4FCD-8093-5F1A90BB70D8Q35012692-079A85EB-8F2B-48D2-A306-DEE4E2224BC8Q35157250-4F8C9590-0673-46AC-92D5-FDC3741110E9Q35594898-7638B174-A7C3-4297-98C0-101B5BA6E7E0Q35760984-603152F4-898B-41F2-85C5-F2CEF525A8D1Q37387453-EC2A3EF8-D6D5-4AFA-9696-0C6B898663A5Q37920182-3D6F9F7D-6AE6-4DAA-B1C9-82F4745CFAFDQ39245295-EF784DC3-C2A9-48FD-93F3-E28F9A459E0EQ40589408-D33750B0-B26B-421B-8E61-570F6FF81D0DQ41481285-3DA225FC-9E40-4F57-B6B5-B3128BF8EECBQ42521707-38129FAB-A6C0-49AE-B58A-3F38B3FACF07Q42982396-98516795-02FE-45FA-9432-E7AAF0C527FCQ42991285-697F7ADF-CFDD-464D-890E-F71EAA89A745Q43050512-FD53641C-0C4B-4808-A7AD-27C3727A8ACBQ43110529-2822F147-EFB7-484B-B94D-073D3B312CC7Q43419136-4F65CA48-E573-42D4-A944-6FC0E926EE0EQ43613004-9E50D9DB-7F7F-43EE-9581-16B310958354Q43734578-115B1548-92E5-49EB-9A54-C1403641AF7EQ44503507-082CAA57-9FFC-462D-8EAA-34AB75D6DDD9Q45745392-EE1F717A-73C2-40D6-A151-257A448FC5ABQ46129674-54C1C34E-57C0-49A4-86B7-4E937DE21F32Q46429728-D4D2915C-8982-4E39-9D2F-CC88D433B4FAQ46737651-7C3FACFE-F3D6-4302-951A-0FDA8EBA2B10Q48007481-BCBC6E6D-2BD4-4ED6-B840-F584F3F80252Q48035268-C056424C-E234-435A-94FA-C1C499D17E14Q50561780-E69DD308-522B-4757-88F1-3B8865E6A756Q50617996-A7BEF318-FC38-4034-A070-29AE8489F2E3Q51270135-19273A64-1C6C-4824-BCDD-42FFA087F54DQ51550710-D9B5E065-FF9F-4577-AB82-8BD59FD55DFCQ51734491-1B7D96CB-2AD0-48BE-BF7B-7B41D14FF323Q51744528-27733F8F-5270-41E5-9561-C2CB1160401CQ51770188-F87E4452-CAF3-401E-8253-85997DA3AE0AQ53748681-67BCEC7E-5D05-4DA7-985A-AA7345D3BE7CQ54384963-3BD15432-8F13-4864-9E47-7268FE84C201Q55041843-2594784B-DE98-4F16-AE1B-6D14DD239D45Q57318801-45F0CB18-59DE-4021-B9AE-B24F12DEEC89Q60571605-03AAB9BD-B1BA-432E-93CA-F69419CB1730
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Massimo Zuin
@ast
Massimo Zuin
@en
Massimo Zuin
@es
Massimo Zuin
@nl
Massimo Zuin
@sl
type
label
Massimo Zuin
@ast
Massimo Zuin
@en
Massimo Zuin
@es
Massimo Zuin
@nl
Massimo Zuin
@sl
prefLabel
Massimo Zuin
@ast
Massimo Zuin
@en
Massimo Zuin
@es
Massimo Zuin
@nl
Massimo Zuin
@sl
P106
P1153
56738533700
P21
P31
P496
0000-0003-3906-4362